Iowa City, IA5 Active Studies

Parkinsons Disease Clinical Trials in Iowa City, IA

Find 5 actively recruiting parkinsons disease clinical trials in Iowa City, IA. Connect with local research sites and explore new treatment options.

5
Active Trials
5
Sponsors
3,084
Enrolling

Recruiting Parkinsons Disease Studies in Iowa City

About Parkinsons Disease Clinical Trials in Iowa City

Parkinson's disease is a progressive nervous system disorder that affects movement, causing tremors, stiffness, and difficulty with balance. It results from the loss of dopamine-producing neurons in the brain. Treatment includes medications, deep brain stimulation, and emerging therapies targeting disease modification.

There are currently 5 parkinsons disease clinical trials recruiting participants in Iowa City, IA. These studies are seeking a combined 3,084 participants. Research is being sponsored by University of Massachusetts, Worcester, NICHD Neonatal Research Network, JHSPH Center for Clinical Trials and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Parkinsons Disease Clinical Trials in Iowa City — FAQ

Are there parkinsons disease clinical trials in Iowa City?

Yes, there are 5 parkinsons disease clinical trials currently recruiting in Iowa City, IA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Iowa City?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Iowa City research site will contact you about next steps.

Are clinical trials in Iowa City free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Iowa City studies also compensate for your time and travel.

What parkinsons disease treatments are being tested?

The 5 active trials in Iowa City are testing new therapies including novel drugs, biologics, and treatment approaches for parkinsons disease.

Data updated July 17, 2026 from ClinicalTrials.gov